BeiGene Ltd (BGNE)
176.50
+1.78
(+1.02%)
USD |
NASDAQ |
Dec 20, 16:00
177.10
+0.60
(+0.34%)
After-Hours: 20:00
BeiGene Total Assets (Quarterly): 5.831B for Sept. 30, 2024
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Theravance Biopharma Inc | 356.10M |
| Merck & Co Inc | 117.53B |
| Dr Reddy's Laboratories Ltd | 5.566B |
| Bristol-Myers Squibb Co | 93.67B |
| Zai Lab Ltd | 985.35M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 2.395B |
| Shareholders Equity (Quarterly) | 3.436B |
| Debt to Equity Ratio | 0.306 |
| Current Ratio | 1.931 |
| Net Debt Paydown Yield | -0.35% |